IL6 is a mediator of inflammation and immune response, can be detected in synovial fluid, and is expressed in osteoarthritis cartilage, making IL-6 inhibition a potential target for the treatment of KOA [45, 46]. This evidence concerns the gene IL6 and osteoarthritis.